Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain. 

According to this study, over the next five years the Amebiasis Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Amebiasis Treatment business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Amebiasis Treatment market by product type, application, key manufacturers and key regions and countries.

This study considers the Amebiasis Treatment value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2024 in section 11.7.

Metronidazole

Paromomycin

Tinidazole

Other

Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2024 in section 11.8.

Hospital

Pharmacy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Dr. Reddy’s Laboratories

Mission Pharmacal

Aceto Corporation

Mylan Pharmaceuticals

Impax Laboratories

Pfizer

Sanofi

Lupin Pharmaceuticals

Glenmark Pharmaceuticals

Sun Pharmaceutical

Heritage Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Amebiasis Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2024.

To understand the structure of Amebiasis Treatment market by identifying its various subsegments.

Focuses on the key global Amebiasis Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Amebiasis Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Amebiasis Treatment submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Amebiasis Treatment Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Amebiasis Treatment Consumption 2013-2023

2.1.2 Amebiasis Treatment Consumption CAGR by Region

2.2 Amebiasis Treatment Segment by Type

2.2.1 Metronidazole

2.2.2 Paromomycin

2.2.3 Tinidazole

2.2.4 Other

2.3 Amebiasis Treatment Consumption by Type

2.3.1 Global Amebiasis Treatment Consumption Market Share by Type (2013-2018)

2.3.2 Global Amebiasis Treatment Revenue and Market Share by Type (2013-2018)

2.3.3 Global Amebiasis Treatment Sale Price by Type (2013-2018)

2.4 Amebiasis Treatment Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.5 Amebiasis Treatment Consumption by Application

2.5.1 Global Amebiasis Treatment Consumption Market Share by Application (2013-2018)

2.5.2 Global Amebiasis Treatment Value and Market Share by Application (2013-2018)

2.5.3 Global Amebiasis Treatment Sale Price by Application (2013-2018)

3 Global Amebiasis Treatment by Players

3.1 Global Amebiasis Treatment Sales Market Share by Players

3.1.1 Global Amebiasis Treatment Sales by Players (2016-2018)

3.1.2 Global Amebiasis Treatment Sales Market Share by Players (2016-2018)

3.2 Global Amebiasis Treatment Revenue Market Share by Players

3.2.1 Global Amebiasis Treatment Revenue by Players (2016-2018)

3.2.2 Global Amebiasis Treatment Revenue Market Share by Players (2016-2018)

3.3 Global Amebiasis Treatment Sale Price by Players

3.4 Global Amebiasis Treatment Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Amebiasis Treatment Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Amebiasis Treatment Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Amebiasis Treatment by Regions

4.1 Amebiasis Treatment by Regions

4.1.1 Global Amebiasis Treatment Consumption by Regions

4.1.2 Global Amebiasis Treatment Value by Regions

4.2 Americas Amebiasis Treatment Consumption Growth

4.3 APAC Amebiasis Treatment Consumption Growth

4.4 Europe Amebiasis Treatment Consumption Growth

4.5 Middle East & Africa Amebiasis Treatment Consumption Growth

5 Americas

5.1 Americas Amebiasis Treatment Consumption by Countries

5.1.1 Americas Amebiasis Treatment Consumption by Countries (2013-2018)

5.1.2 Americas Amebiasis Treatment Value by Countries (2013-2018)

5.2 Americas Amebiasis Treatment Consumption by Type

5.3 Americas Amebiasis Treatment Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Amebiasis Treatment Consumption by Countries

6.1.1 APAC Amebiasis Treatment Consumption by Countries (2013-2018)

6.1.2 APAC Amebiasis Treatment Value by Countries (2013-2018)

6.2 APAC Amebiasis Treatment Consumption by Type

6.3 APAC Amebiasis Treatment Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Amebiasis Treatment by Countries

7.1.1 Europe Amebiasis Treatment Consumption by Countries (2013-2018)

7.1.2 Europe Amebiasis Treatment Value by Countries (2013-2018)

7.2 Europe Amebiasis Treatment Consumption by Type

7.3 Europe Amebiasis Treatment Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Amebiasis Treatment by Countries

8.1.1 Middle East & Africa Amebiasis Treatment Consumption by Countries (2013-2018)

8.1.2 Middle East & Africa Amebiasis Treatment Value by Countries (2013-2018)

8.2 Middle East & Africa Amebiasis Treatment Consumption by Type

8.3 Middle East & Africa Amebiasis Treatment Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.2 Amebiasis Treatment Distributors

10.3 Amebiasis Treatment Customer

11 Global Amebiasis Treatment Market Forecast

11.1 Global Amebiasis Treatment Consumption Forecast (2018-2023)

11.2 Global Amebiasis Treatment Forecast by Regions

11.2.1 Global Amebiasis Treatment Forecast by Regions (2018-2023)

11.2.2 Global Amebiasis Treatment Value Forecast by Regions (2018-2023)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Amebiasis Treatment Forecast by Type

11.8 Global Amebiasis Treatment Forecast by Application

12 Key Players Analysis

12.1 Dr. Reddy’s Laboratories

12.1.1 Company Details

12.1.2 Amebiasis Treatment Product Offered

12.1.3 Dr. Reddy’s Laboratories Amebiasis Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.1.4 Main Business Overview

12.1.5 Dr. Reddy’s Laboratories News

12.2 Mission Pharmacal

12.2.1 Company Details

12.2.2 Amebiasis Treatment Product Offered

12.2.3 Mission Pharmacal Amebiasis Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.2.4 Main Business Overview

12.2.5 Mission Pharmacal News

12.3 Aceto Corporation

12.3.1 Company Details

12.3.2 Amebiasis Treatment Product Offered

12.3.3 Aceto Corporation Amebiasis Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.3.4 Main Business Overview

12.3.5 Aceto Corporation News

12.4 Mylan Pharmaceuticals

12.4.1 Company Details

12.4.2 Amebiasis Treatment Product Offered

12.4.3 Mylan Pharmaceuticals Amebiasis Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.4.4 Main Business Overview

12.4.5 Mylan Pharmaceuticals News

12.5 Impax Laboratories

12.5.1 Company Details

12.5.2 Amebiasis Treatment Product Offered

12.5.3 Impax Laboratories Amebiasis Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.5.4 Main Business Overview

12.5.5 Impax Laboratories News

12.6 Pfizer

12.6.1 Company Details

12.6.2 Amebiasis Treatment Product Offered

12.6.3 Pfizer Amebiasis Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.6.4 Main Business Overview

12.6.5 Pfizer News

12.7 Sanofi

12.7.1 Company Details

12.7.2 Amebiasis Treatment Product Offered

12.7.3 Sanofi Amebiasis Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.7.4 Main Business Overview

12.7.5 Sanofi News

12.8 Lupin Pharmaceuticals

12.8.1 Company Details

12.8.2 Amebiasis Treatment Product Offered

12.8.3 Lupin Pharmaceuticals Amebiasis Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.8.4 Main Business Overview

12.8.5 Lupin Pharmaceuticals News

12.9 Glenmark Pharmaceuticals

12.9.1 Company Details

12.9.2 Amebiasis Treatment Product Offered

12.9.3 Glenmark Pharmaceuticals Amebiasis Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.9.4 Main Business Overview

12.9.5 Glenmark Pharmaceuticals News

12.10 Sun Pharmaceutical

12.10.1 Company Details

12.10.2 Amebiasis Treatment Product Offered

12.10.3 Sun Pharmaceutical Amebiasis Treatment Sales, Revenue, Price and Gross Margin (2016-2018)

12.10.4 Main Business Overview

12.10.5 Sun Pharmaceutical News

12.11 Heritage Pharmaceuticals

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Amebiasis Treatment

Table Product Specifications of Amebiasis Treatment

Figure Amebiasis Treatment Report Years Considered

Fi